Bahar Ataeinia

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “HER3 Differentiates Basal From Claudin Type Triple Negative Breast Cancer and Contributes to Drug and Microenvironmental Induced Resistance”.

HER3 Differentiates Basal From Claudin Type Triple Negative Breast Cancer and Contributes to Drug and Microenvironmental Induced Resistance

Frontiers in Oncology(2020)10.3389/fonc.2020.554704

N/A

0DataRank · unranked

13 citations

Bahar Ataeinia, Veronica Zehnder, Kevin Lin, Lauren Grove, Pedram Heidari +2 more

Artificial Intelligence and the Future of Diagnostic and Therapeutic Radiopharmaceutical Development

PET Clinics(2021)10.1016/j.cpet.2021.06.008

N/A

0DataRank · unranked

30 citations

Pedram Heidari, Bahar Ataeinia

Non-invasive Detection of Immunotherapy-Induced Adverse Events

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4641

N/A

0DataRank · unranked

1 citations

Pedram Heidari, Bahar Ataeinia, Nicoleta Sinevici, Meghan E. Sise, Robert B. Colvin +3 more

Peroxidasin Deficiency Re-programs Macrophages Toward Pro-fibrolysis Function and Promotes Collagen Resolution in Liver

Cellular and Molecular Gastroenterology and Hepatology(2022)10.1016/j.jcmgh.2022.01.015

N/A

0DataRank · unranked

33 citations

Derek J. Erstad, Stephen C. Barrett, Shadi Salloum, Shijia Zhu, Tongqi Qian +17 more

Immune Checkpoint Inhibitor-Mediated Cancer Theranostics with Radiolabeled Anti-Granzyme B Peptide

Pharmaceutics(2022)10.3390/pharmaceutics14071460

N/A

0DataRank · unranked

13 citations

Pedram Heidari, Bahar Ataeinia, Nicoleta Sinevici, Alyssa Granito, Hritik Mahajan Kumar +3 more

HER3 PET Imaging Predicts Response to Pan Receptor Tyrosine Kinase Inhibition Therapy in Gastric Cancer

Molecular Imaging and Biology(2022)10.1007/s11307-022-01763-9

N/A

0DataRank · unranked

4 citations

Carolina de Aguiar Ferreira, Nicholas J. Rotile, Bahar Ataeinia, Shriya Krishna, Onofrio A. Catalano +5 more

Data from Non-invasive Detection of Immunotherapy-Induced Adverse Events

(2023)10.1158/1078-0432.c.6530544

N/A

0DataRank · unranked

0 citations

Pedram Heidari, Bahar Ataeinia, Nicoleta Sinevici, Meghan E. Sise, Robert B. Colvin +3 more

Data from Non-invasive Detection of Immunotherapy-Induced Adverse Events

(2023)10.1158/1078-0432.c.6530544.v1

N/A

0DataRank · unranked

0 citations

Pedram Heidari, Bahar Ataeinia, Nicoleta Sinevici, Meghan E. Sise, Robert B. Colvin +3 more

Allysine-Targeted Molecular MRI Enables Early Prediction of Chemotherapy Response in Pancreatic Cancer

Cancer Research(2024)10.1158/0008-5472.can-23-3548

N/A

0DataRank · unranked

6 citations

Shadi A. Esfahani, Shriya Krishna, Bahar Ataeinia, Iris Y. Zhou, Nicholas J. Rotile +6 more

Evaluating the Impact of Adjunctive Partial Cryoablation on Dual Checkpoint Inhibitor Immunotherapy Response in a Murine Model

Radiology Imaging Cancer(2024)10.1148/rycan.230187

N/A

0DataRank · unranked

3 citations

Perry Hampilos, Emily Austin, Bahar Ataeinia, Abigail MacPherson, Thomas J. LaSalle +2 more

LAMP1 as a Target for PET Imaging in Adenocarcinoma Xenograft Models

Pharmaceuticals(2025)10.3390/ph18081122

N/A

0DataRank · unranked

1 citations

Arvin Haj‐Mirzaian, Lital Ben-Naim, Shadi A. Esfahani, Asier Marcos-Vidal, Umar Mahmood +2 more